Clinical Trials List
2017-02-10 - 2025-12-31
Phase III
Recruiting2
Terminated1
ICD-10C34.80
Malignant neoplasm of overlapping sites of unspecified bronchus and lung
ICD-10C34.81
Malignant neoplasm of overlapping sites of right bronchus and lung
ICD-10C34.82
Malignant neoplasm of overlapping sites of left bronchus and lung
ICD-10C7A.090
Malignant carcinoid tumor of the bronchus and lung
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9162.8
Malignant neoplasm of other parts of bronchus or lung
-
Trial Applicant
ICON Clinical Research Pte Ltd
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/02/01
Investigators and Locations
Co-Principal Investigator
- KUO-HSUAN HSU Division of Thoracic Medicine
- JENG-SEN TSENG Division of Thoracic Medicine
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Han-Lin Hsu Division of Thoracic Medicine
- Yu-Tien Tzeng Division of Thoracic Medicine
- HsingJin Eugene Liu Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Chih-Yen Tu 無
- 陳鴻仁 無
- Chen Chia-Hung 無
- 廖偉志 無
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
80 participants
-
Global
300 participants
